233 Users Online
Hydrocephalus Shunts Market Segmentation By Product - Hydrocephalus Valves | Hydrocephalus Catheters | Neuronavigation Systems
In 2022, the overall hydrocephalus shunts market size reached a valuation of US$ 294.5 Mn. Analyzing further, the PMR Group projects that the market would register a CAGR of 3.5% during the forecast years from 2022 to 2032, reaching a value of approximately 415.5 Mn by its end.
Given their higher potential for use in treating hydrocephalus and other brain illnesses, these healthcare items have garnered much attention in the last few years. An increase in the proportion of aging people, rising incidence of neurological and brain illnesses, and the growing use of sophisticated programmable valves are all factors contributing to the global hydrocephalus shunting market key trends and opportunities. Therefore, such variables may significantly improve the demand for hydrocephalus shunts throughout the foreseeable period and become a lucrative business for market participants.
|
Attributes |
Details |
|
Hydrocephalus Shunts Market CAGR (2022 to 2032) |
3.5% |
|
Hydrocephalus Shunts Market Size (2022) |
US$ 294.5 Mn |
|
Hydrocephalus Shunts Market (2032) |
US$ 415.5 Mn |
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Generally, babies and children under 5 are more likely than adults to have hydrocephalus, and on the other hand, the condition is also common among persons 60 and older. So, the sales of hydrocephalus shunts in western countries have increased in the last few years with the rising geriatric population. While in Eastern Asia and African countries, the prevailing high birth rate ratio is regarded as a significant factor in the growing demand for surgical procedures for hydrocephalus.
The recent expansion of several regional markets for hydrocephalus shunts is explained by the rising elderly population, the heightened frequency of neurological and brain illnesses, and the expanding use of sophisticated programmable valves. The most modern programmable valves, shunts, and antisiphon devices are now preferred by most neurosurgeons for such conditions.
The significant demand for cutting-edge Medtronic programmable shunts for the treatment of hydrocephalus is a result of the rising prevalence of brain illnesses and improving health care infrastructure in the third world economies.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionIn accordance with the paper "Global Hydrocephalus Epidemiology and Incidence: Systematic Review and Meta-analysis," released by the Journal of Neurosurgery in the year 2019, low-income and middle-income nations, notably those in Africa and Latin America, bear the greatest burden of hydrocephalus. However, the lack of sufficient healthcare infrastructure in most of these countries have
According to this report, Sub-Saharan Africa experiences well over 225,000 new instances of infant hydrocephalus annually, or 750 new cases for every 100,000 live births. So, the rising assistance and endowments for healthcare improvement by international organizations are predicted to present a lot of favourable opportunities for the growth of the hydrocephalus shunt business.
The management of CSF with shunts is a key component of the therapeutic strategy for hydrocephalus. As a result, the increased prevalence of hydrocephalus is expected to lead to a greater demand for hydrocephalus shunts, which in turn would spur opportunities for the market.
During the pandemic years, as a result of the lockdown procedures implemented worldwide, extensive clinical research and operations got delayed for non-urgent treatments to lessen the strain on the healthcare system. Consequently, the market demand for hydrocephalus shunts dropped down significantly, and the development of hydrocephalus shunt industries turned incidental.
According to a study published in the Neurology Online Journal, COVID-19 may be to blame for individuals acquiring new neurological conditions in 2020, including hydrocephalus. Moreover, the sales of hydrocephalus shunt might be hampered by concerns over infections brought on by the use of this product, as per one of the experts at PMR. Other than that, the introduction of stunt-free treatment for hydrocephalus is predicted to capture a substantial market share in the future.
Sales Team
Client Partner
Which Product Segment is Likely to Lead the Hydrocephalus Shunts Market?
As per the global hydrocephalus shunts market survey report of 2021, the product segment of hydrocephalus valves was figured out to be the largest. Moreover, it is predicted that throughout the projection period, it will also register the fastest CAGR of nearly 3.6% in comparison to other product segments.
Even further, the sub-segments of hydrocephalus valves, like fixed pressure valves and adjustable pressure valves, are observed to be getting popular simultaneously and are growing at comparable terms.
Which Type of Hydrocephalus Shunts has the Higher Growth Potential?
Based on type, the ventriculoperitoneal market segment accounted for the highest revenue share generated by the overall market in the year 2021. Additionally, even during forecast years, this category is anticipated to register a noteworthy CAGR of 3.7%.
As multiple pulmonary emboli and shunt nephritis are a couple of the most serious side effects of VA shunts, so the new VP shunt components are anticipated to lower shunt malfunctions and improve patient care during neurosurgery procedures.
|
Attributes |
Hydrocephalus Shunts Market |
|
CAGR (2022 to 2032) |
3.5% |
|
Market Value (2022) |
US$ 294.5 Mn |
|
Growth Factor |
The rising frequency of brain and neurological illnesses among the general population of both developed and emerging economies. |
|
Future Opportunities |
The expansion of the healthcare sector and the adoption of several public campaigns to raise public knowledge of cerebral shunts. |
|
Market Trends |
Market’s expansion is being provided by a number of technical developments, including the creation of anti-siphon devices. |
|
Attributes |
Cephalosporin Drugs Market |
|
CAGR (2022 to 2032) |
6% |
|
Market Value (2022) |
US$ 15 Bn |
|
Growth Factor |
The increased rate of contagious diseases like HIV and TB, and the rising financing for the research and development of antibiotics. |
|
Future Opportunities |
Increasing funding for R&D by concerned organization due to emergence of several types of new pathogens in different regions. |
|
Market Trends |
Several businesses are engaged in the strategic creation of new items to capture maximum market share by popularizing their brand. |
|
Attributes |
Peripheral Stent Market |
|
CAGR (2022 to 2032) |
5.5% |
|
Market Value (2022) |
US$ 18 Bn |
|
Growth Factor |
The increase in elderly population around the world has resulted in more incidences of peripheral disorders and its treatment. |
|
Future Opportunities |
Introduction of cutting-edge equipment that can be used efficiently in the healthcare institutes with inferior system and facilities. |
|
Market Trends |
The top three firms own a significant portion of the market making the overall business very opportunistic for new players. |
Why does the United State Dominate the Global Hydrocephalus Shunts Market?
As per the analysis, North America is the leading region for the market, with the United States contributing more than 80% of the revenue share in this sector. By virtue of the existence of important medical device businesses in the area, the United States is predicted to retain its dominance over the global hydrocephalus shunts market during the forecast years.
According to an article from the American Society for Biochemistry and Molecular Biology, 280,000 traumatic brain injuries or TBIs results in hospitalizations per year in the United States alone, creating a huge need for surgical procedure for hydrocephalus.
How UK Healthcare Sector would benefit from Rising Demand for Hydrocephalus Shunts in Europe?
As per a research report, 110 occurrences of infantile hydrocephalus were expected to occur in a European cohort for every 100,000 live births in the following years. This seems to create more opportunities for the market players present in the countries like the United Kingdom, Germany, France, and Spain, having well-established healthcare infrastructure and ample facilities for medical tourism.
Due to the adoption of technologically sophisticated shunts, improved healthcare infrastructure, and increased awareness of the hydrocephalic syndrome, the United Kingdom is also predicted to have the greatest market share in comparison to other European economies. Moreover, the UK is quite famous for its excellent medical tourism sector, which would be instrumental in furthering the market performance in the country.
Why Japan is emerging as a New Market for Global Players?
Japan is emerging to be a lucrative market for the regional as well as global hydrocephalus shunts industry players. In the country, sufficient government support to establish and develop industries for manufacturing and export of healthcare devices has played a crucial role in the advancement of the hydrocephalus shunts market trends.
These businesses are making significant investments in the research and development of neurosurgical devices in an effort to lessen the social and financial burden of hydrocephalus, which is thought to be the major factor for the emergence of Japan as a prominent region for the market.
Will South Korea contribute to a Lucrative Hydrocephalus Shunts Market Share?
Asia Pacific is projected to be a major marketplace for the import and sales of hydrocephalus shunts in the coming days. This is expected to be promising for the regional market players mostly located in the East Asian Countries. So, the market for hydrocephalus shunts in South Korea is thus anticipated to rise as a result of the increase in product demand and shortage described above.
Also, as more doctors choose programmable shunts to lessen infections and malfunctions brought on by frequent shunt operations, the Codman Hakim programmable valve price is reducing. This is also anticipated to invariably supplement the hydrocephalus shunts market growth in the adjacent Markets of South Korea.
Most of the companies operating in the global hydrocephalus shunts market have a high adoption rate for organic growth tactics, including new releases and regulatory approvals. Additionally, the current focus of hydrocephalus shunt manufacturers on the development of hydrocephalus catheters' prospective redesign might accelerate this segment's growth during the forecast years.
In order to minimize infections and failures with conventional shunts, industry participants are creating new devices that can monitor shunts in patients. To give an illustration, the FDA designated Rhaeos, Inc.'s "FlowSense," which is a non-invasive temperature sensor, as a groundbreaking device.
MIT researchers presented and validated a novel design approach for hydrocephalus catheters in a work that was accepted for publication in the Royal Society Interface in the year 2020. This new design aims to solve the main issue of frequently getting blocked and could shield brain shunt catheters from failure.
Recent developments in the Hydrocephalus Shunts Industry
|
Attributes |
Details |
|
Forecast Period |
2022 to 2032 |
|
Historical Data Available For |
2015 to 2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Countries Covered |
|
|
By Market Segments |
|
|
Key Companies Profiled |
|
|
Pricing |
Available Upon Request |
Hydrocephalus Shunts Industry by Type
Hydrocephalus Shunts Industry by Product
Hydrocephalus Shunts Industry by Age Group
Hydrocephalus Shunts Industry by End User
Hydrocephalus Shunts Industry by Region
The global hydrocephalus shunts market was estimated at US$ 294.5 Mn in 2022.
The global hydrocephalus shunts market likely grow at a rate of 3.5% through 2032.
The global hydrocephalus shunts market is expected to garner US$ 415.5 Mn by 2032.
US is projected to be best performing regional hydrocephalus shunts market.
The ventriculo-peritoneal segment is expected to be the highest contributor in the hydrocephalus shunts market.
